Skip to content
  • Clinical Studies
  • Pharma GMP
  • Pharma Tips
  • Stability Studies
  • Pharma Books
  • Schedule M

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • SOP – Blog Post
  • Toggle search form

SOP for Customer Complaints Handling for Transdermal Patches

Posted on By

SOP for Customer Complaints Handling for Transdermal Patches

Standard Operating Procedure for Customer Complaints Handling for Transdermal Patches

1) Purpose

To establish procedures for receiving, documenting, evaluating, and resolving customer complaints related to transdermal patches, ensuring timely resolution and continuous improvement in product quality and customer satisfaction.

2) Scope

This SOP applies to all personnel involved in customer service, quality assurance (QA), regulatory affairs, and production departments responsible for handling customer complaints related to transdermal patches.

3) Responsibilities

3.1 Customer Service Representative: Receives and documents customer complaints.
3.2 QA Manager: Oversees the investigation and resolution of complaints.
3.3 Regulatory Affairs: Ensures compliance with regulatory reporting requirements.
3.4 Production: Provides input on manufacturing issues related to complaints.
3.5 Senior Management: Reviews trends in complaints and approves corrective actions.

See also  SOP for Root Cause Analysis in Transdermal Patches Production

4) Procedure

4.1 Complaint Receipt:

4.1.1 Receive customer complaints through designated channels (e.g., phone, email, web portal).

4.1.2 Document complaint details including product name, batch number, description of complaint, and contact information.

4.2 Evaluation and Investigation:

4.2.1 Assign a unique complaint number and classify the complaint based on severity and potential impact on patient safety.

4.2.2 Initiate an investigation

to determine the root cause of the complaint, involving relevant departments as necessary.

4.3 Corrective and Preventive Actions (CAPA):

4.3.1 Develop and implement corrective actions to address immediate issues identified by the investigation.

4.3.2 Implement preventive actions to prevent recurrence of similar complaints in the future.

See also  SOP for Training Personnel in Transdermal Patches Production

4.4 Communication:

4.4.1 Communicate with the customer to acknowledge receipt of the complaint and provide updates on the investigation and resolution process.

4.4.2 Provide a formal response to the customer detailing the findings of the investigation and any corrective actions taken.

4.5 Documentation and Reporting:

4.5.1 Maintain accurate and complete records of all customer complaints, investigations, and resolutions.

4.5.2 Report serious complaints to regulatory authorities as per regulatory requirements.

5) Abbreviations, if any

SOP: Standard Operating Procedure
QA: Quality Assurance
CAPA: Corrective and Preventive Actions

6) Documents, if any

Complaint Forms
Investigation Reports
Corrective and Preventive Action Plans

7) Reference, if any

See also  SOP for In-process Testing for Transdermal Patches

ISO 13485: Medical devices – Quality management systems
FDA Guidance for Industry: Handling of Customer Complaints

8) SOP Version

Version 1.0

Transdermal Patches Tags:Adhesion Testing Protocol, Analytical Method Development SOP, Assay of Active Ingredient SOP, Contamination Prevention SOP, Documentation SOP, Equipment calibration SOP, Equipment Cleaning SOP, Final Product Inspection SOP, Formulation development SOP, Homogeneity Testing SOP, In-process Testing SOP, Microbial Testing SOP, Personnel Training SOP, Process Optimization SOP, Process Validation SOP, Quality Control Transdermal Patches, Raw Material Inspection SOP, Release Rate Testing SOP, Sample Collection SOP, Sterility Maintenance SOP, Storage Conditions Transdermal Patches, Thickness Testing Procedure, Transdermal Patch Manufacturing SOP, Transdermal Patch Stability Testing, Waste Handling SOP

Post navigation

Previous Post: SOP for Ring Extrusion Machine
Next Post: SOP for Safety and Environmental Controls in Aerosol Manufacturing

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2025 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version